Research Program
Shiau Research Group
Life Course Epidemiology | HIV & Aging | Molecular Epidemiology | Translational Science
The Shiau Research Group investigates how biological, clinical, and social factors shape health across the life course, with a particular focus on HIV and aging. We integrate epidemiologic methods, molecular biomarkers, experimental collaborations, and real-world data to understand disease mechanisms and inform strategies for improving long-term health.
Research Areas
|
We investigate the development and progression of chronic conditions and multisystem morbidity among individuals growing up and aging with HIV, with a focus on long-term health trajectories and opportunities to promote healthy aging. |
We integrate epigenomic and other multi-omics data with epidemiologic studies to investigate biological aging, inflammation, immune regulation, and molecular pathways underlying chronic disease. |
|
We study how maternal health, perinatal HIV exposure, antiretroviral therapy, and inflammation during critical developmental periods influence child health, biological aging, and health across the lifespan. |
We leverage large-scale administrative health data to investigate treatment patterns, medication use and safety, chronic conditions, and long-term health outcomes, with a focus on generating evidence to inform clinical care and improve population health. |
Highlighted Active Funding
- NIH/NIA RF1AG099751 (MPI: Chintan Dave and Stephanie Shiau)
Using real-world data to inform the epidemiology of cardiometabolic conditions and their treatment among older adults with HIV
Project Period: 09/2026 – 08/2030 - NIH/NICHD R01HD122687 (MPI: Ryan Ross and Stephanie Shiau)
Impact of maternal integrase inhibitor use on offspring fat and bone development
Project Period: 07/2026 – 06/2031 - NIH/NICHD R01HD111550 (PI: Stephanie Shiau)
Maternal inflammation in relation to offspring epigenetic aging and neurodevelopment
Project Period: 06/2023 – 05/2027 - NIH, NIMH, P30MH144896 (MPI: Lish Ndhlovu and Tricia Burdo)
New York-New Jersey Center for Actionable NeuroHIV Biomarkers and Integrated Omics (NYJ-CAN-BIO)
Role: Co-Director, Biosignature Core
Project Period: 08/2026 – 04/2030 - NIH/NIDA K01DA053157 (PI: Stephanie Shiau)
Leveraging large-scale administrative claims data to evaluate prescription opioid use, risks, and outcomes in older adults living with HIV
Project Period: 06/01/2021 – 04/30/2027
Highlighted Completed Research Funding
- PHACS Emerging Research Pilot Award (PI: Stephanie Shiau)
Maternal ART, maternal inflammation, and epigenetic biomarkers in children with perinatal exposure to HIV
Project Period: 05/2024 –- 07/2025 - NIH/NIDCR (MPI: Modupe Coker and Stephanie Shiau)
Uncovering the Biological Link between Oral and Mental health in Adolescents Living with HIV (uBLOoM)
Project Period: 08/2023 – 07/2026 - NIH/NICHD R21HD104558 (PI: Stephanie Shiau)
Leveraging NICHD DASH biospecimens to isolate the effects of HIV infection and HIV exposure on epigenetic profiles in infants
Project Period: 09/2020 – 08/2023 - Thrasher Research Fund, Early Career Award
Signature maternal immune activation markers of growth and infectious morbidity in HEU children
Project Period: 09/2019 – 08/2021
